On the other hand, in NRAS-mutated melanoma data on survival result conflicting: some studies report no difference in patients’ survival (74, 75), whereas in one study NRAS mutations were associated with improved survival in metastatic disease (78, 79). This evidence concerns the gene NRAS and metastatic neoplasm.